OTCPK:ZICX

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Zicix Corporation, through its subsidiary, Texas Mobile Health, Inc., provides diagnostic medical imaging services in Houston, Texas. More Details


Snowflake Analysis

Weak fundamentals or lack of information.

Share Price & News

How has Zicix's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: ZICX's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

7.5%

ZICX

-2.3%

US Healthcare

-0.8%

US Market


1 Year Return

26.5%

ZICX

21.0%

US Healthcare

13.8%

US Market

Return vs Industry: ZICX exceeded the US Healthcare industry which returned 21% over the past year.

Return vs Market: ZICX exceeded the US Market which returned 13.8% over the past year.


Shareholder returns

ZICXIndustryMarket
7 Day7.5%-2.3%-0.8%
30 Day-20.8%-4.3%-5.0%
90 Day226.1%1.8%10.1%
1 Year26.5%26.5%22.6%21.0%16.4%13.8%
3 Year90.5%90.5%23.9%18.5%36.9%27.8%
5 Yearn/a50.1%39.4%85.0%64.2%

Price Volatility Vs. Market

How volatile is Zicix's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Zicix undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Zicix is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Zicix has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of ZICX's management and see if the CEO's compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don't know where to start, we recommend reading through Zicix regulatory filings here.
  • Explore potentially undervalued companies in the Healthcare industry.

Future Growth

How is Zicix forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

13.9%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Zicix has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of ZICX’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on theOTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Zicix's filings and announcementshere.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Zicix performed over the past 5 years?

73.6%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: ZICX is currently unprofitable.

Growing Profit Margin: ZICX is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: Unable to establish if ZICX's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.

Accelerating Growth: Unable to compare ZICX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ZICX is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (31.1%).


Return on Equity

High ROE: ZICX's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Next Steps

Financial Health

How is Zicix's financial position?


Financial Position Analysis

Short Term Liabilities: ZICX has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: ZICX has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: ZICX has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: ZICX's has negative shareholder equity, so we do not need to check if its debt has reduced over time.

Debt Coverage: Insufficient data to determine if ZICX's debt is well covered by operating cash flow.

Interest Coverage: Insufficient data to determine if ZICX's interest payments on its debt are well covered by EBIT.


Balance Sheet


Next Steps

Dividend

What is Zicix current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate ZICX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ZICX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if ZICX's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ZICX's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of ZICX's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

William Petty

no data

Tenure

Mr. William Petty serves as President and Chief Executive Officer at Zicix Corporation. Mr. Petty’s innate ability to work with global financing entities like the IFC, as well as with international governm ...


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.6%.


Top Shareholders

Company Information

Zicix Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Zicix Corporation
  • Ticker: ZICX
  • Exchange: OTCPK
  • Founded: 1979
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$10.261m
  • Shares outstanding: 681.78m
  • Website: https://www.zicixgroup.com

Number of Employees


Location

  • Zicix Corporation
  • 710 North Post Oak Road
  • Suite 400
  • Houston
  • Texas
  • 77024
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
ZICXOTCPK (Pink Sheets LLC)YesCommon StockUSUSDDec 2007

Biography

Zicix Corporation, through its subsidiary, Texas Mobile Health, Inc., provides diagnostic medical imaging services in Houston, Texas. It offers cardiac diagnostic services, including echocardiogram, stress ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/27 06:03
End of Day Share Price2020/09/24 00:00
Earnings2019/12/31
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.